Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2021 | 4 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
High dose rifampin for 2 months vs standard dose rifampin for 4 months, to treat TB infection: Protocol of a 3-arm randomized trial (2R2).
PLoS One. 2023 Feb 2;18(2):e0278087. doi: 10.1371/journal.pone.0278087. eCollection 2023.
PLoS One. 2023.
PMID: 36730240
Free PMC article.
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial.
Oxlade O, Benedetti A, Adjobimey M, Alsdurf H, Anagonou S, Cook VJ, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, Hill PC, Johnston J, Khan FA, Long R, Nguyen NV, Nguyen TA, Obeng J, Ruslami R, Schwartzman K, Trajman A, Valiquette C, Menzies D.
Oxlade O, et al.
Lancet Public Health. 2021 May;6(5):e272-e282. doi: 10.1016/S2468-2667(20)30261-9. Epub 2021 Mar 22.
Lancet Public Health. 2021.
PMID: 33765453
Free article.
Clinical Trial.
Item in Clipboard
The mTST - An mHealth approach for training and quality assurance of tuberculin skin test administration and reading.
Moayedi-Nia S, Barss L, Oxlade O, Valiquette C, Ly MX, Campbell JR, Lan Z, Nsengiyumva P, Fregonese F, Lisboa Bastos M, Sampath D, Winters N, Menzies D.
Moayedi-Nia S, et al.
PLoS One. 2019 Apr 17;14(4):e0215240. doi: 10.1371/journal.pone.0215240. eCollection 2019.
PLoS One. 2019.
PMID: 30995275
Free PMC article.
Clinical Trial.
Item in Clipboard
Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation.
Yanes-Lane M, Trajman A, Bastos ML, Oxlade O, Valiquette C, Rufino N, Fregonese F, Menzies D.
Yanes-Lane M, et al.
BMC Public Health. 2021 Jan 21;21(1):177. doi: 10.1186/s12889-021-10195-z.
BMC Public Health. 2021.
PMID: 33478452
Free PMC article.
Clinical Trial.
Item in Clipboard
Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016.
Cegielski JP, Chan PC, Lan Z, Udwadia ZF, Viiklepp P, Yim JJ, Menzies D.
Cegielski JP, et al.
Clin Infect Dis. 2021 Dec 6;73(11):e3929-e3936. doi: 10.1093/cid/ciaa621.
Clin Infect Dis. 2021.
PMID: 33124668
Free PMC article.
Item in Clipboard
Comparing the Diagnostic Performance of QuantiFERON-TB Gold Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D.
Oh CE, et al.
Clin Infect Dis. 2021 Sep 7;73(5):e1116-e1125. doi: 10.1093/cid/ciaa1822.
Clin Infect Dis. 2021.
PMID: 33289038
Free PMC article.
Item in Clipboard
Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial.
Oxlade O, Trajman A, Benedetti A, Adjobimey M, Cook VJ, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, Hill PC, Johnston J, Long R, Obeng J, Ruslami R, Valiquette C, Menzies D.
Oxlade O, et al.
BMJ Open. 2019 Mar 20;9(3):e025831. doi: 10.1136/bmjopen-2018-025831.
BMJ Open. 2019.
PMID: 30898826
Free PMC article.
Item in Clipboard
Cite
Cite